Condition
Influenza With Pneumonia
Total Trials
5
Recruiting
1
Active
2
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 60/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Active Not Recruiting1
Unknown1
Terminated1
Completed1
Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04530799Active Not RecruitingPrimary
Prospective Observational Trial of IAPA
NCT06202521Phase 2Terminated
CX-4945 in Viral Community Acquired Pneumonia
NCT03748069RecruitingPrimary
Influenza Associated Aspergillosis In-depth Investigation
NCT03391492CompletedPrimary
Invasive Pulmonary Aspergillosis Complicating Influenza Infection
NCT04313946Unknown
Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays
Showing all 5 trials